Correlation Between Indaptus Therapeutics and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on Indaptus Therapeutics and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Maravai Lifesciences.
Diversification Opportunities for Indaptus Therapeutics and Maravai Lifesciences
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Indaptus and Maravai is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Maravai Lifesciences
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.06 times more return on investment than Maravai Lifesciences. However, Indaptus Therapeutics is 1.06 times more volatile than Maravai Lifesciences Holdings. It trades about 0.01 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.01 per unit of risk. If you would invest 156.00 in Indaptus Therapeutics on September 12, 2024 and sell it today you would lose (56.00) from holding Indaptus Therapeutics or give up 35.9% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Indaptus Therapeutics vs. Maravai Lifesciences Holdings
Performance |
Timeline |
Indaptus Therapeutics |
Maravai Lifesciences |
Indaptus Therapeutics and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Indaptus Therapeutics and Maravai Lifesciences
The main advantage of trading using opposite Indaptus Therapeutics and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |